Strs Ohio Pfizer Inc Transaction History

Strs Ohio

$24.7 Billion
Q1 2024

A detailed history of Strs Ohio transactions in Pfizer Inc stock. As of the latest transaction made, Strs Ohio holds 2,106,718 shares of PFE stock, worth $59 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,106,718

Previous 2,219,232 5.07%

Holding current value

$59 Million

Previous $63.9 Million 8.5%

% of portfolio

0.24%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $2.91 Million - $3.35 Million	-112,514 Reduced 5.07%	2,106,718 $58.5 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $71,779 - $93,233	-2,747 Reduced 0.12%	2,219,232 $63.9 Million
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $1.06 Million - $1.24 Million	-33,013 Reduced 1.46%	2,221,979 $73.7 Million
Q2 2023 Jul 31, 2023	SELL	$36.12 - $41.79 $5.15 Million - $5.95 Million	-142,482 Reduced 5.94%	2,254,992 $82.7 Million
Q1 2023 Aug 02, 2023	BUY	$39.39 - $51.28 $5.61 Million - $7.31 Million	142,482 Added 6.32%	2,397,474 $97.8 Million

Q1 2023 Apr 27, 2023	SELL	$39.39 - $51.28 $5.6 Million - $7.29 Million	-142,232 Reduced 5.6%	2,397,474 $97.8 Million
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $5.14 Million - $6.7 Million	122,997 Added 5.09%	2,539,706 $130 Million
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $172,283 - $210,314	3,937 Added 0.16%	2,416,709 $106 Million
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $2.49 Million - $2.96 Million	53,597 Added 2.27%	2,412,772 $127 Million
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $16.5 Million - $20.4 Million	359,823 Added 18.0%	2,359,175 $122 Million
Q4 2021 Jan 24, 2022	BUY	$41.32 - $61.25 $7.96 Million - $11.8 Million	192,751 Added 10.67%	1,999,352 $118 Million
Q3 2021 Oct 22, 2021	SELL	$39.25 - $50.42 $4.18 Million - $5.37 Million	-106,444 Reduced 5.56%	1,806,601 $77.7 Million
Q2 2021 Jul 26, 2021	SELL	$35.91 - $40.68 $3.02 Million - $3.42 Million	-84,043 Reduced 4.21%	1,913,045 $74.9 Million
Q1 2021 Apr 23, 2021	SELL	$33.49 - $37.77 $8.84 Million - $9.96 Million	-263,833 Reduced 11.67%	1,997,088 $72.4 Million
Q4 2020 Jan 25, 2021	SELL	$33.47 - $42.56 $7.11 Million - $9.05 Million	-212,545 Reduced 8.59%	2,260,921 $83.2 Million
Q3 2020 Dec 14, 2020	SELL	$31.75 - $37.25 $6.22 Million - $7.3 Million	-195,962 Reduced 7.34%	2,473,466 $90.8 Million
Q2 2020 Jul 23, 2020	SELL	$30.12 - $36.54 $8.61 Million - $10.4 Million	-285,701 Reduced 9.67%	2,669,428 $87.3 Million
Q1 2020 Apr 23, 2020	BUY	$27.03 - $38.62 $14 Million - $19.9 Million	516,334 Added 21.17%	2,955,129 $96.5 Million
Q4 2019 Jan 24, 2020	SELL	$32.92 - $37.36 $8.83 Million - $10 Million	-268,209 Reduced 9.91%	2,438,795 $95.6 Million
Q3 2019 Oct 21, 2019	SELL	$32.49 - $42.13 $5.73 Million - $7.44 Million	-176,514 Reduced 6.12%	2,707,004 $97.3 Million
Q2 2019 Jul 25, 2019	SELL	$36.98 - $41.52 $3.27 Million - $3.67 Million	-88,407 Reduced 2.97%	2,883,518 $125 Million
Q1 2019 Apr 19, 2019	SELL	$37.5 - $41.2 $905,812 - $995,186	-24,155 Reduced 0.81%	2,971,925 $126 Million
Q4 2018 Jan 23, 2019	BUY	$38.47 - $43.86 $1.74 Million - $1.98 Million	45,159 Added 1.53%	2,996,080 $131 Million
Q3 2018 Oct 19, 2018	SELL	$34.47 - $41.81 $10.3 Million - $12.5 Million	-299,249 Reduced 9.21%	2,950,921 $130 Million
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $5.64 Million - $6.01 Million	-170,942 Reduced 5.0%	3,250,170 $118 Million
Q1 2018 Apr 20, 2018	SELL	$31.91 - $37.02 $7.44 Million - $8.63 Million	-233,169 Reduced 6.38%	3,421,112 $121 Million
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $2.97 Million - $3.15 Million	-89,360 Reduced 2.39%	3,654,281 $132 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $116 Million - $128 Million	3,743,641	3,743,641 $134 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account